Make your own free website on Tripod.com

Sponsors of KIN Consulting & Research Services:

tnplogo.gif

The KIN Consulting & Research Services Company

Google
WWW The KIN Consulting & Research Services




   The KIN Consulting & Research Services is the engine for research and development with in The KIN Consortium. We have innovative medical concepts, excellent relationships with Scientists around the world (Both Academic & Industrial), & we have gained the recognition of politicians & investment bankers around the World.   Here we are on the food chain of the medical industry (Big Pharmaceuticals ==> Biotechnology Companies (Stem Cell Research Centers)==> Medical Schools ==> Theoretical Research Companies).

                                   Chairman's Views

Join our campaign by submitting a complaint to the SEC! "SEC Contact Form" (Click HERE)

animated banner
"A New Trend" (Click HERE)

animated banner
" State of the Medical Industry" (Click HERE)

animated banner
"Connecting The Medical Industry with Investors" (Click)

   Dear Readers,

   I have an excellent idea that I would like to show you. Its comes in two parts:

     1) The KIN Intravenous Solution (Glucose & Cloned lymphocytes).
     2) The ISCE (International Stem Cell Exchange) A market for trading individual stems of the DNA Chromosome & new antibodies from all around the world.

   The combination of the aforementioned ideas should ramp up the growth rate of new antibiotics coming to market.   Especially since the ISCE focuses on Monoclonal Antibodies (testing individual stems against the new antibodies) for refining medicine.

   The simple truth of the matter is that the Pharmaceutical Industry is going to have a rather drastic slide.   The fact is that there is a disease that is killing white blood cells.   As the disease grows, the source for new antibodies subsequently declines.   They are inversely correlated  (rate of disease vs rate of new antibodies).   As a result there will be a drop in earnings forecasts, which will make it harder to raise money for the pharmaceutical companies.

   By definition the solution is The KIN Intravenous Solution (Glucose + Cloned White Blood Cells).   If you need more information on the protocols for ex vivo production of white blood cells, then please contact the Chairman at khalidnatto@gmail.com.

   For more information please watch our videos and buy our research below.    We also got the support of Senator Tom Harkin of Iowa, Senator Gordon Smith of Oregon, & Senator Sam Brownback of Kansas with regards to the cloning of white blood cells. Check out the Reviews page below.

1. Senator Gordon Smith USA TODAY
https://ssl.capwiz.com/usatoday/bio/userletter/?letter_id=370974171&content_dir=y
2. Senator Sam Brownback Star Tribune
https://ssl.capwiz.com/startribune/bio/userletter/?letter_id=380119091&content_dir=y

    The Senator's on the Hill found my research to be particularly interesting because it was the common ground between the huge ethical controversy over financing embryonic vs adult stem cell research.   Artificial white blood cells can be cloned without delving into the whole ethical issue. Voila!

   The KIN Consulting and Research Services Company sells the analysis and the visions of Chairman Natto:

  I. Research Reports on Antibiotics related Companies:

A) The KIN Consulting & Research Services presents the "OSI Pharmaceuticals (OSIP)" April 19th, 2006
B) The KIN Consulting & Research Services presents the "Biogen IDEC (BIIB)" April 19th, 2006
C) The KIN Consulting & Research Services presents the "Genentech Inc. (DNA)" April 19th, 2006
D) The KIN Consulting & Research Services presents the "Amgen Inc. (AMGN)" April 20th, 2006
E) The KIN Consulting & Research Services presents the "Novartis AG (NVS)" April 20th, 2006
F) The KIN Consulting & Research Services presents the "Abbott Lab" (ABT) April 20th, 2006
G) The KIN Consulting & Research Services presents the "Merck & Co., Inc." (MRK) April 20th, 2006
H) The KIN Consulting & Research Services presents the "Bayer Corp." (BAY) April 21st, 2006
I) The KIN Consulting & Research Services presents the "Bristol-Myers Squibb Company" (BMY) April 21st, 2006
J) The KIN Consulting & Research Services presents the "AFFYMETRIX, INC." (AFFX) April 21st, 2006
K) The KIN Consulting & Research Services presents the "Eli Lilly & Company" (LLY) April 22nd, 2006
L) The KIN Consulting & Research Services presents the "Sanofi Aventis" (SNY) April 22nd, 2006
M) The KIN Consulting & Research Services presents the "Schering Plough Corp." (SGP) April 22nd, 2006
N) The KIN Consulting & Research Services presents the "ASTRAZENECA PLC" (AZN) April 22nd, 2006
O) The KIN Consulting & Research Services presents the "Cardinal Health Inc." (CAH) April 22nd, 2006
P) The KIN Consulting & Research Services presents the " ADOLOR CORPORATION" (ADLR) April 22nd, 2006
Q) The KIN Consulting & Research Services presents the " Spectrum Pharmaceuticals, Inc." (SPPI) April 24th, 2006
R) The KIN Consulting & Research Services presents the " Array BioPharma, Inc. "(ARRY) April 24th, 2006
S) The KIN Consulting & Research Services presents the " AmerisourceBergen Corporation "(ABC) April 24th, 2006
T) The KIN Consulting & Research Services presents the "Applera Corporation-Celera Genomics Group " (ABI) April 24th, 2006

  II. Clone Lymphocyte Project:

A) The KIN Consulting & Research Services presents, "The Future of Medicine is The ISCE"
B) RESEARCH "Dr. Wagner's Congressional Hearings on Cloning Lymphocytes"
C) RESEARCH: "The NIH's Stem Cell Task Force"
D) RESEARCH: "Daley's Congressionnal Testimony on Cloning lymphocytes"
E) RESEARCH "NIH's Application for Money"
F) New RESEARCH " International Finance Corp. IFC's Application for Money"
G) Members only Focus Group of Scientists
H) (New Commentary from Senators) Reviews Page
I) The KIN Promotional Gear

  III. Ultrasound PDA Project:

A) The KIN Diagnostic PDA of the Future

  IV. Mobile Office Industry Standard:

A) Chairman's Model for "Mobile Office"

  V. Researchers may use these International databases:

A) Chairman's International Search Engines for Researchers

Recent articles on the medical industry:

Solution Graphics

For New Clients Contact The Chairman at Email: khalidnatto@gmail.com

First name:
Last name:
Email address:
Company:
Address 1:
Address 2:
City:
State:
Zip code:
Phone:
Request information on product?
Topic
  

===================================================================

Disclaimer of Warranty and Limitation of Liability
The information, products and services on this web site or letter are provided on an "AS IS," "WHERE IS" and "WHERE AVAILABLE" basis.  The KIN Consortium does not warrant the information or services provided herein or your use of this web site generally, either expressly or impliedly, for any particular purpose and expressly disclaims any implied warranties, including but not limited to, warranties of title, non-infringement, merchantability or fitness for a particular purpose. The KIN Consortium  will not be responsible for any loss or damage that could result from interception by third parties of any information or services made available to you via this web site. Although the information provided to you on this web site is obtained or compiled from sources we believe to be reliable, The KIN Consortium  cannot and does not guarantee the accuracy, validity, timeliness or completeness of any information or data made available to you for any particular purpose. Neither The KIN Consortium , nor any of its affiliates, directors, officers or employees, nor any third party vendor, will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or interruption of this web site, or resulting from the act or omission of any other party involved in making this web site, the data contained herein or the products or services offered on this web site available to you, or from any other cause relating to your access to, inability to access, or use of the web site or these materials, whether or not the circumstances giving rise to such cause may have been within the control of The KIN Consortium  or of any vendor providing software or services. In no event will The KIN Consortium  or any such parties be liable to you, whether in contract or tort, for any direct, special, indirect, consequential or incidental damages or any other damages of any kind even if The KIN Consortium  or any other such party has been advised of the possibility thereof. This limitation on liability includes, but is not limited to, the transmission of any viruses which may infect a user's equipment, failure of mechanical or electronic equipment or communication lines, telephone or other interconnect problems (e.g., you cannot access your internet service provider), unauthorized access, theft, operator errors, strikes or other labor problems. The KIN Consortium  cannot and does not guarantee continuous, uninterrupted or secure access to the web site.

Proprietary Rights
All right, title and interest in this web site and any content contained herein is the exclusive property of The KIN Consortium , except as otherwise stated. Unless otherwise specified, this web site is for your personal and non-commercial use only and you may print, copy and download any information or portion of this web site for your personal use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, frame, create derivative works from, transfer, or otherwise use in any other way for commercial or public purposes in whole or in part any information, software, products or services obtained from this web site, except for the purposes expressly provided herein, without The KIN Consortium's prior written approval. If you copy or download any information or software from this web site, you agree that you will not remove or obscure any copyright or other notices or legends contained in any such information.

The KIN Consortium and other trademarks and service marks referenced herein are trademarks and service marks of The KIN Consortium . The names of other companies and third-party products or services mentioned herein may be the trademarks or service marks of their respective owners. You are prohibited from using any marks for any purpose including, but not limited to use as metatags on other pages or sites on the World Wide Web without the written permission of The KIN Consortium  or such third party, which may own the marks.

Pursuant to Section 512(c)(2) of the Copyright Act, The KIN Consortium  designates the following agent to receive notifications of claimed infringement: Khalid I Natto, The KIN Consortium , Email:
kalnatto2000@yahoo.com, Website: http://khalidnatto.tripod.com 

Use of Links
This web site contains links to third party web sites. These links are provided only as a convenience. The inclusion of any link is not and does not imply an affiliation, sponsorship, endorsement, approval, investigation, verification or monitoring by The KIN Consortium of any information contained in any third party web site. In no event shall The KIN Consortium be responsible for the information contained on that site or your use of or inability to use such site. You should also be aware that the terms and conditions of such site and the site's privacy policy may be different from those applicable to your use of this web site.

Feedback, subscriptions, ideas? Email: kalnatto2000@yahoo.com